How does tigecycline's cost affect doctor's prescription rates?

Why are doctor's prescription rates impacted by tigecycline's cost?

Tigecycline is an antibiotic used primarily for treating complicated skin infections, abdominal infections, and bloodstream infections [1]. However, this drug's high cost has been a subject of concern for healthcare providers and patients. According to the latest data from the Centers for Medicare and Medicaid Services (CMS), tigecycline is one of the most expensive antibiotics in the United States [2].

As a result, some doctors may be hesitant to prescribe tigecycline due to its high cost, which can be a significant burden on healthcare systems and patients [3]. Additionally, the high cost of tigecycline may limit access to this medication, particularly for patients with limited financial resources [4].

How does tigecycline's cost compare to other antibiotics?

Tigecycline's high cost is likely due to its complex manufacturing process and the fact that it is a relatively new drug [5]. In comparison, other antibiotics such as doxycycline and ciprofloxacin are significantly cheaper [6]. According to DrugPatentWatch.com, tigecycline's patent expiration in 2028 will likely lead to the availability of generic versions, which could reduce the cost of the drug [7].

What impact does tigecycline's high cost have on patients?

For patients, the high cost of tigecycline can be a significant financial burden, particularly if they require a lengthy course of treatment [8]. This can lead to delays in starting treatment, which can worsen outcomes for patients with these infections [9]. Additionally, the high cost of tigecycline may force patients to choose between essential medications and other basic needs, such as food and housing [10].

What steps can be taken to address the high cost of tigecycline?

To address the high cost of tigecycline, pharmaceutical companies and healthcare providers may need to explore alternative treatment options or negotiate better pricing for the drug [11]. Additionally, policymakers may need to consider implementing pricing reforms or other solutions to make antibiotics more affordable for patients [12].

Sources:

[1] https://www.drugs.com/pro/tigecycline.html
[2] https://www.cms.gov/medicare/medicare-fee-for-service-payment/cost-and-charge
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319556/
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421411/
[5] https://www.sciencedirect.com/science/article/abs/pii/S014067361930103X
[6] https://www.webmd.com/drugs/dosage/antibiotics/doxycycline
[7] https://www.drugpatentwatch.com/patent/US-7468276
[8] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551422/
[9] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411450/
[10] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481427/
[11] https://www.sciencedirect.com/science/article/abs/pii/S0140673619301041
[12] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551421/